Enalapril Maleate which is an ACE inhibitor is administered in the form of Enalapril maleate. It is used for the treatment of of hypertension, diabetic nephropathy and chronic heart failure. Reference standards of Enalapril Maleate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Enalapril Maleate
Catalogue No.:PA 05 04000
CAS :
Molecular Formula : C24H32N2O9
Molecular Weight : 492.52
(2S)-1-[(2S)-2-[[(1R)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic Acid
Catalogue No.:PA 05 04010
Molecular Formula : C20H28N2O5
Molecular Weight : 376.45
Enalapril (1R)-Isomer Maleate
Catalogue No.:PA 05 04011
(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino] propanoic Acid
Catalogue No.:PA 05 04020
Molecular Formula : C15H21NO4
Molecular Weight : 279.33
Enalaprilat Dihydrate
Catalogue No.:PA 05 04030
Molecular Formula : C18H28N2O7
Molecular Weight : 384.42
Enalaprilat
Catalogue No.:PA 05 04031
Molecular Formula : C18H24N2O5
Molecular Weight : 348.39
Enalapril Diketopiperazine
Catalogue No.:PA 05 04040
Molecular Formula : C20H26N2O4
Molecular Weight : 358.43
Enalaprilat Phenylethyl Ester
Catalogue No.:PA 05 04050
Molecular Formula : C26H32N2O5
Molecular Weight : 452.54
Enalapril Butyl Ester Analog
Catalogue No.:PA 05 04060
Molecular Formula : C22H32N2O5
Molecular Weight : 404.50
Enalapril Cyclohexyl ECPPA Analog
Catalogue No.:PA 05 04070
Molecular Formula : C15H27NO4
Molecular Weight : 285.38
Enalapril Cyclohexyl Analog
Catalogue No.:PA 05 04080
Molecular Formula : C20H34N2O5
Molecular Weight : 382.49
1H-Imidazole
Catalogue No.:PA 05 04090
Molecular Formula : C3H4N2
Molecular Weight : 68.08
Enalapril Cyclohexyl Analogue Trifluoroacetic Acid Salt
Catalogue No.:PA 05 0040081
Molecular Formula : C22H35F3N2O7
Molecular Weight : 496.52
N-((S)-1-Carboxy-3-phenylpropyl)-N-nitroso-L-alanyl-L-proline
Catalogue No.:PA 05 0041001
Molecular Formula : C18H23N3O6
Molecular Weight : 377.4
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
